ZEVRA THERAPEUTICS, INC. Total Assets

• ZEVRA THERAPEUTICS, INC. showed an increase of +59.8% in Total Assets from 2024 to 2025.
• This data is from ZEVRA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2015: $14.12 million | Q2 2015: $66.54 million | Q3 2015: $61.42 million | Q1 2016: $111.94 million | Q2 2016: $104.63 million | Q3 2016: $94.54 million | Q1 2017: $75.64 million | Q2 2017: $69.05 million | Q3 2017: $59.31 million | Q1 2018: $42.65 million | Q2 2018: $34.00 million | Q3 2018: $18.74 million | Q1 2019: $19.87 million | Q2 2019: $13.01 million | Q3 2019: $12.89 million | Q1 2020: $8.89 million | Q2 2020: $12.33 million | Q3 2020: $11.20 million | Q1 2021: $90.44 million | Q2 2021: $138.80 million | Q3 2021: $137.19 million | Q1 2022: $125.71 million | Q2 2022: $124.26 million | Q3 2022: $119.55 million | Q1 2023: $106.60 million | Q2 2023: $105.52 million | Q3 2023: $138.98 million | Q1 2024: $151.28 million | Q2 2024: $144.41 million | Q3 2024: $191.55 million | Q1 2025: $172.71 million | Q2 2025: $256.28 million | Q3 2025: $270.12 million.
• Over the full 12 years of available data (2014 to 2025), ZEVRA THERAPEUTICS, INC.'s Total Assets has grown by 1,976.2%.
• Historical annual values: Fiscal year 2025: $284.73 million | Fiscal year 2024: $178.13 million | Fiscal year 2023: $172.33 million | Fiscal year 2022: $115.34 million | Fiscal year 2021: $132.94 million | Fiscal year 2020: $11.21 million | Fiscal year 2019: $10.51 million | Fiscal year 2018: $26.75 million | Fiscal year 2017: $52.46 million | Fiscal year 2016: $84.89 million | Fiscal year 2015: $54.59 million | Fiscal year 2014: $13.71 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026